Autopsy report · NCT01678053
Efficacy Study of Botulinum Toxin (BOTOX) Injections to Treat Vocal Fold Granulomas
Cause of deathSlow enrollment
“Was not able to recruit patients for randomization.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- Phillip Song, MD
- Sponsor type
- University, hospital or other
- Conditions
- Contact Ulcer of Vocal Folds; Granuloma of Vocal Cords; Granuloma, Laryngeal; Granuloma
- Interventions
- onabotulinumtoxinA; omeprazole (proton pump inhibitor)
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection
“Unable to recruit patients.” - Efficacy of PRGF Supplementation After TMJ Arthrocentesis in Patients With TMJ Osteoarthritis
“Could not recruit participants due to their refusal to be randomized in the study.” - A Single-center Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of LCAR-L10D Cell Formulations Targeting CD19 and CD22 in Patients With CD19- and/or CD22-Positive Relapsed/Refractory B-cell Lymphoma
“Suitable patients were not recruited” - Changes in Abdominal Tissues Induced by Magnetic Device - CT Evaluation
“It wasn't possible to recruit the desired number of patients.” - Individualization Treatment Through a Self-managed Web-based Solution in Ulcerative Colitis
“not able to recruit patients”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.